BESLR.E — Besler Gida ve Kimya Sanayi ve Ticaret AS Balance Sheet
0.000.00%
- TRY8.35bn
- TRY14.81bn
- TRY25.00bn
Annual balance sheet for Besler Gida ve Kimya Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 57.5 | 65 | 453 | 64.1 | 2,109 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,650 | 2,274 | 6,754 | 6,854 | 10,016 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,348 | 3,272 | 11,415 | 12,762 | 16,348 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 935 | 1,115 | 4,915 | 7,857 | 8,109 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,540 | 4,722 | 17,398 | 23,279 | 27,801 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,093 | 2,456 | 8,059 | 9,970 | 11,802 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,334 | 3,438 | 10,524 | 13,271 | 15,991 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,206 | 1,284 | 6,874 | 10,008 | 11,810 |
| Total Liabilities & Shareholders' Equity | 3,540 | 4,722 | 17,398 | 23,279 | 27,801 |
| Total Common Shares Outstanding |